PDE4D and familial dilated cardiomyopathy: Therefore, it is essential to identify the predominantly elevated PDE4D isoforms in DCM cardiomyocytes (Wang et al., 2017; Xu, Fu, et al., 2022), which may present promising targets for developing safe and effective therapeutic drugs.